Kestra Medical Technologies (KMTS) Stock Price, News & Analysis

Company Overview

Kestra Medical Technologies, Inc. is a medical device company focused on developing and commercializing technologies designed to help protect patients at risk of sudden cardiac arrest. The company’s primary product is the ASSURE wearable cardioverter defibrillator, or WCD, which is intended to provide temporary protection for patients who may be at elevated risk of life-threatening ventricular arrhythmias.

The ASSURE system continuously monitors a patient’s heart rhythm and is designed to detect potentially dangerous arrhythmias, including ventricular tachycardia and ventricular fibrillation. When appropriate, the device can deliver a therapeutic shock to help restore a normal heart rhythm. Its wearable format is intended to support patients during periods when they are not yet candidates for, or are waiting to receive, a permanently implanted cardiac defibrillator.

Kestra’s products combine wearable hardware, cardiac monitoring, automated arrhythmia detection and connectivity intended to support physicians and care teams. The company’s operations are focused primarily on the United States, where the ASSURE system has received regulatory clearance and is used in the management of patients at risk for sudden cardiac arrest.

Key Stats

• Today's Range: $26.99 to $29.01
• 50-Day Range: $22.85 to $28.68
• 52-Week Range: $17.34 to $30.00
• Volume: 521,897 shs
• Average Volume: 351,057 shs
• Market Capitalization: $1.62 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $28.38
• Consensus Rating: Hold

Kestra Medical Technologies Stock Analysis - MarketRank™

Kestra Medical Technologies scored higher than 27% of companies evaluated by MarketBeat, and ranked 774th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.5 / 5
• Analyst Rating: Hold

Consensus Rating

Kestra Medical Technologies has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on no strong buy ratings, 4 buy ratings, 2 hold ratings, and 1 sell rating.

Upside/Downside

The consensus price target for Kestra Medical Technologies is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Kestra Medical Technologies has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Kestra Medical Technologies are expected to grow in the coming year, from ($2.45) to ($2.12) per share.

Price to Book Value per Share Ratio

Kestra Medical Technologies has a P/B Ratio of 6.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.81% of the float of Kestra Medical Technologies has been sold short.

Short Interest Ratio / Days to Cover

Kestra Medical Technologies has a short interest ratio ("days to cover") of 7.28.

Change versus previous month

Short interest in Kestra Medical Technologies has recently increased by 4.93%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Kestra Medical Technologies does not currently pay a dividend.

Dividend Growth

Kestra Medical Technologies does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.48

News Sentiment

Kestra Medical Technologies has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Kestra Medical Technologies this week, compared to 3 articles on an average week.

MarketBeat Follows

2 people have added Kestra Medical Technologies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Kestra Medical Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,997,473.00 in company stock.

Percentage Held by Insiders

5.30% of the stock of Kestra Medical Technologies is held by insiders.

Percentage Held by Institutions

Kestra Medical Technologies has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 9/14/2026
• Today: 10/17/2026
• Fiscal Year End: 4/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:KMTS
• Previous Symbol: NASDAQ:KMTS
• CIK: 1877184
• Web: www.kestramedical.com
• Phone: (425) 279-8002
• Fax: N/A
• Employees: 443
• Year Founded: 2021

Price Target and Rating

• Average Price Target for Kestra Medical Technologies: $28.38
• High Price Target: $32.00
• Low Price Target: $17.00
• Potential Upside/Downside: +4.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.43
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.67)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$131.61 million
• Net Margins: -140.43%
• Pretax Margin: -140.14%
• Return on Equity: -63.83%
• Return on Assets: -44.76%

Debt

• Debt-to-Equity Ratio: 0.33
• Current Ratio: 4.69
• Quick Ratio: 4.69

Sales & Book Value

• Annual Sales: $95.13 million
• Price / Sales: 17.05
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.45 per share
• Price / Book: 6.12

Miscellaneous

• Outstanding Shares: 59,560,000
• Free Float: 56,405,000
• Market Cap: $1.62 billion
• Optionable: N/A
• Beta: 0.51